AU2011231688B2 — Medicated module with user selection
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2014-12-04 · 11y expired
What this patent protects
A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module (4) containing a single dose of a secondary medicament and where both medicaments are deli…
USPTO Abstract
A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module (4) containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle (3). The medicated module (4) is user selectable so that it will deliver a priming dose of a primary medicament or both the primary and secondary medicaments. The module (4) also contains a needle guard (42) that locks after dose delivery. The needle guard (42) prevents accidental needle sticks before and after an injection. A locking collar (66) rotates during use as an inner protrusion (12) follows three paths (14, 15, 16) of a track (13) located on the outer surface of a body housing (10). When the inner facing protrusion (12) is in the third path (16), it encounters a hard stop and a rotational bias that locks the guard (42) from further retraction and thus covers the sharp distal end of the needle (3).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.